<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>ir-100-17981</identifier><datestamp>2016-01-15T06:53:09Z</datestamp><dc:title>Naphthoquinone-based chalcone hybrids and derivatives: synthesis and potent activity against cancer cell lines</dc:title><dc:creator>JARDIM, GAM</dc:creator><dc:creator>GUIMARAES, TT</dc:creator><dc:creator>PINTO, MDFR</dc:creator><dc:creator>CAVALCANTI, BC</dc:creator><dc:creator>DE FARIAS, KM</dc:creator><dc:creator>PESSOA, C</dc:creator><dc:creator>GATTO, CC</dc:creator><dc:creator>NAIR, DK</dc:creator><dc:creator>NAMBOOTHIRI, INN</dc:creator><dc:creator>DA SILVA, EN</dc:creator><dc:subject>LAPACHONE-BASED 1,2,3-TRIAZOLES</dc:subject><dc:subject>NOR-ALPHA-LAPACHONE</dc:subject><dc:subject>BETA-LAPACHONE</dc:subject><dc:subject>HETEROCYCLIC-DERIVATIVES</dc:subject><dc:subject>ANTIMALARIAL ACTIVITY</dc:subject><dc:subject>ANTITUMOR-ACTIVITY</dc:subject><dc:subject>TRYPANOSOMA-CRUZI</dc:subject><dc:subject>CYTOTOXICITY</dc:subject><dc:subject>AGENTS</dc:subject><dc:subject>INHIBITORS</dc:subject><dc:description>Novel naphthoquinone-based chalcones were prepared from the reaction between 3-bromo-nor-beta-lapachone and amino-chalcones. Lapachone derivatives are also described here. All the substances were evaluated against cancer and normal cell lines and several compounds demonstrated potent antitumor activity.</dc:description><dc:publisher>ROYAL SOC CHEMISTRY</dc:publisher><dc:date>2016-01-15T06:53:09Z</dc:date><dc:date>2016-01-15T06:53:09Z</dc:date><dc:date>2015</dc:date><dc:type>Article</dc:type><dc:identifier>MEDCHEMCOMM, 6(1)120-130</dc:identifier><dc:identifier>2040-2503</dc:identifier><dc:identifier>2040-2511</dc:identifier><dc:identifier>http://dx.doi.org/10.1039/c4md00371c</dc:identifier><dc:identifier>http://dspace.library.iitb.ac.in/jspui/handle/100/17981</dc:identifier><dc:language>en</dc:language></oai_dc:dc>